TGFB1 and diabetes mellitus: In nonobese diabetic (NOD) mice, transgenic expression of TGF-β in the inflamed islets significantly delays diabetes development, in that TGF-β disables the transition of primed autoreactive CD8+ T cells to cytotoxic effectors within the pancreas, significantly impairing their diabetogenic capacity (159).